CASI Pharmaceuticals (NASDAQ:CASI) Stock Quotes, Forecast and News Summary

Q: What sector and industry does CASI Pharmaceuticals (CASI) operate in?

CASI Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

CASI Pharmaceuticals Stock (NASDAQ: CASI) stock price, news, charts, stock research, profile.

Open	$2.80
Close	$3.07
Volume / Avg.	71.50K / 41.76K
Day Range	$2.75 - $3.47
52 Wk Range	2.05 - 8.19
Market Cap	$43.14M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	35
Short Interest	0.39%
Days to Cover	1

Recent News

CASI Pharmaceuticals Blood Cancer Drug Shows Encouraging Clinical Efficacy In Chinese Patients

CASI Pharmaceuticals and BioInvent share promising results for BI-1206 in treating relapsed/refractory indolent Non-Hodgkin's Lymphoma patients in China. Preliminary data reveals clinical efficacy with partial and complete responses, affirming positive safety profiles.

Vandana Singh

Why VOXX International Shares Are Trading Higher By Around 12%; Here Are 20 Stocks Moving Premarket

Gainers

Lisa Levin

Why NanoVibronix Shares Surged Over 25%; Here Are 82 Biggest Movers From Friday

Gainers Golden Sun Education Group Limited (NASDAQ: GSUN) shares surged 92.1% to settle at $52.89 on Friday.

Lisa Levin

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Rating and Forecast

4.0

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	$2.80
Close	$3.07
Volume / Avg.	71.50K / 41.76K
Day Range	$2.75 - $3.47
52 Wk Range	2.05 - 8.19
Market Cap	$43.14M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	35
Short Interest	0.39%
Days to Cover	1

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy CASI Pharmaceuticals (CASI) stock?

You can purchase shares of CASI Pharmaceuticals (NASDAQ:CASI) through any online brokerage.

View our list of the best stock brokerages

Who are CASI Pharmaceuticals (CASI) competitors?

Other companies in CASI Pharmaceuticals’s space includes: Serina Therapeutics (AMEX:SER), Fortress Biotech (NASDAQ:FBIO), Kezar Life Sciences (NASDAQ:KZR), Estrella Immunopharma (NASDAQ:ESLA) and Gain Therapeutics (NASDAQ:GANX).

What is the forecast, or price target, for CASI Pharmaceuticals (CASI) stock?

CASI Pharmaceuticals has a consensus price target of $9.33.

What is the current price for CASI Pharmaceuticals (CASI)?

The stock price for CASI Pharmaceuticals (NASDAQ: CASI) is $2.79 last updated December 26, 2024 at 9:29 AM EST.

Does CASI Pharmaceuticals (CASI) pay a dividend?

There are no upcoming dividends for CASI Pharmaceuticals.

When is CASI Pharmaceuticals (NASDAQ:CASI) reporting earnings?

CASI Pharmaceuticals’s Q4 earnings are confirmed for Thursday, March 27, 2025.

Is CASI Pharmaceuticals (CASI) going to split?

There is no upcoming split for CASI Pharmaceuticals.

What sector and industry does CASI Pharmaceuticals (CASI) operate in?

CASI Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Comments

CASI Pharmaceuticals

CASI Pharmaceuticals (CASI) Forecast